Insider Trading Alert - KEX, TJX, SBH, MTGE And CACI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 2, 2013, 167 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $696.00 to $31,440,000.00.

Highlighted Stocks Traded by Insiders:

Kirby (KEX) - FREE Research Report

Ivey William G. who is President-Kirby Inland Marine at Kirby sold 1,000 shares at $95.77 on Dec. 2, 2013. Following this transaction, the President-Kirby Inland Marine owned 15,722 shares meaning that the stake was reduced by 5.98% with the 1,000-share transaction.

The shares most recently traded at $93.80, down $1.97, or 2.1% since the insider transaction. Historical insider transactions for Kirby go as follows:

  • 4-Week # shares sold: 6,473
  • 12-Week # shares sold: 6,473
  • 24-Week # shares sold: 221,669

The average volume for Kirby has been 291,600 shares per day over the past 30 days. Kirby has a market cap of $5.4 billion and is part of the services sector and transportation industry. Shares are up 52.58% year-to-date as of the close of trading on Monday.

Kirby Corporation, through its subsidiaries, provides marine transportation and diesel engine services primarily in the United States. Its Marine Transportation segment provides transportation services for the inland and coastal markets. The company has a P/E ratio of 21.7. Currently there are 8 analysts that rate Kirby a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KEX - FREE

TheStreet Quant Ratings rates Kirby as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, revenue growth, expanding profit margins, good cash flow from operations and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Kirby Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TJX Companies (TJX) - FREE Research Report

Meyrowitz Carol who is Ceo - Tjx at TJX Companies sold 60,000 shares at $63.22 on Dec. 2, 2013. Following this transaction, the Ceo - Tjx owned 799,920 shares meaning that the stake was reduced by 6.98% with the 60,000-share transaction.

The shares most recently traded at $62.19, down $1.03, or 1.65% since the insider transaction. Historical insider transactions for TJX Companies go as follows:

  • 4-Week # shares sold: 60,068
  • 12-Week # shares sold: 112,868
  • 24-Week # shares sold: 112,868

The average volume for TJX Companies has been 3.0 million shares per day over the past 30 days. TJX Companies has a market cap of $45.0 billion and is part of the services sector and retail industry. Shares are up 47.73% year-to-date as of the close of trading on Monday.

The TJX Companies, Inc. operates as an off-price apparel and home fashions retailer in the United States and internationally. The company operates in four segments: Marmaxx, HomeGoods, TJX Canada, and TJX Europe. The stock currently has a dividend yield of 0.92%. The company has a P/E ratio of 21.2. Currently there are 10 analysts that rate TJX Companies a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TJX - FREE

TheStreet Quant Ratings rates TJX Companies as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full TJX Companies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Sally Beauty Holdings (SBH) - FREE Research Report

Eisenberg Marshall E who is Director at Sally Beauty Holdings sold 20,000 shares at $28.21 on Dec. 2, 2013. Following this transaction, the Director owned 80,000 shares meaning that the stake was reduced by 20% with the 20,000-share transaction.

The shares most recently traded at $27.74, down $0.47, or 1.69% since the insider transaction. Historical insider transactions for Sally Beauty Holdings go as follows:

  • 4-Week # shares sold: 21,214
  • 12-Week # shares sold: 21,214
  • 24-Week # shares sold: 49,535

The average volume for Sally Beauty Holdings has been 1.5 million shares per day over the past 30 days. Sally Beauty Holdings has a market cap of $4.6 billion and is part of the services sector and specialty retail industry. Shares are up 19.39% year-to-date as of the close of trading on Monday.

Sally Beauty Holdings, Inc., through its subsidiaries, operates as a specialty retailer and distributor of professional beauty supplies primarily in North America, South America, and Europe. The company operates in two segments, Sally Beauty Supply and Beauty Systems Group. The stock currently has a dividend yield of 5.62%. The company has a P/E ratio of 19.0. Currently there are 4 analysts that rate Sally Beauty Holdings a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SBH - FREE

TheStreet Quant Ratings rates Sally Beauty Holdings as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, good cash flow from operations, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Sally Beauty Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

American Capital Mortgage Investment (MTGE) - FREE Research Report

Harvey Larry K who is Director at American Capital Mortgage Investment bought 2,000 shares at $18.70 on Dec. 2, 2013. Following this transaction, the Director owned 8,500 shares meaning that the stake was reduced by 30.77% with the 2,000-share transaction.

The shares most recently traded at $18.40, down $0.30, or 1.63% since the insider transaction. Historical insider transactions for American Capital Mortgage Investment go as follows:

  • 4-Week # shares bought: 2,000
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 28,000
  • 24-Week # shares sold: 1,000

The average volume for American Capital Mortgage Investment has been 727,500 shares per day over the past 30 days. American Capital Mortgage Investment has a market cap of $999.3 million and is part of the financial sector and real estate industry. Shares are down 22.15% year-to-date as of the close of trading on Monday.

American Capital Mortgage Investment Corp. operates as a real estate investment trust (REIT) in the United States. The stock currently has a dividend yield of 14.82%. Currently there are 4 analysts that rate American Capital Mortgage Investment a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MTGE - FREE

TheStreet Quant Ratings rates American Capital Mortgage Investment as a sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself, deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share. Get the full American Capital Mortgage Investment Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CACI International (CACI) - FREE Research Report

London J Phillip who is Director at CACI International sold 13,447 shares at $72.56 on Dec. 2, 2013. Following this transaction, the Director owned 98,610 shares meaning that the stake was reduced by 12% with the 13,447-share transaction.

The shares most recently traded at $72.05, down $0.51, or 0.7% since the insider transaction. Historical insider transactions for CACI International go as follows:

  • 4-Week # shares sold: 9,531
  • 12-Week # shares sold: 10,506
  • 24-Week # shares sold: 10,506

The average volume for CACI International has been 200,600 shares per day over the past 30 days. CACI International has a market cap of $1.7 billion and is part of the services sector and diversified services industry. Shares are up 30.42% year-to-date as of the close of trading on Monday.

CACI International Inc., together with its subsidiaries, provides information solutions and services to the U.S. federal government and commercial markets in North America and internationally. The company has a P/E ratio of 11.6. Currently there is 1 analyst that rates CACI International a buy, 3 analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CACI - FREE

TheStreet Quant Ratings rates CACI International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full CACI International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

Big Pharma and the Sellers of Its Products Now Have a Problem

Big Pharma and the Sellers of Its Products Now Have a Problem

The Worm Has Obviously Turned: Market Recon

The Worm Has Obviously Turned: Market Recon

The Trump Tax Plan Will Make These 15 Stocks Huge Winners: Market Recon

The Trump Tax Plan Will Make These 15 Stocks Huge Winners: Market Recon

Cramer: Can the Pummeled Transports Get Back on Track?

Cramer: Can the Pummeled Transports Get Back on Track?